Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Mahr

Showing results (21-30 of 158) with videos related to

Pageof 16
Sort By:
Presse Medicale (Paris, France : 1983)|November 7, 2016
[Adult Langerhans cell histiocytosis]Mathilde de Menthon, Véronique Meignin, Alfred Mahr, et al.
Rheumatology International|June 27, 2024
Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitionersLukas Joos, Solange Gonzalez Chiappe, Thomas Neumann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2018
Nomenklatur der kutanen Vaskulitiden - deutschsprachige Definitionen des Dermatologischen Anhanges zur Chapel Hill Consensus ConferenceCord Sunderkötter, Peter Lamprecht, Alfred Mahr, et al.
Presse Medicale (Paris, France : 1983)|March 16, 2013
L47. Single-organ vasculitis: conceptual and practical considerationsAlfred Mahr, Maxime Battistella, Jean-David Bouaziz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2018
Nomenclature of cutaneous vasculitides - German translation of the dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesCord Sunderkötter, Peter Lamprecht, Alfred Mahr, et al.
Presse Medicale (Paris, France : 1983)|September 4, 2012
[Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects]Séverin Chaigne-Delalande, Mathilde de Menthon, Estibaliz Lazaro, et al.
Clinical Reviews in Allergy & Immunology|February 14, 2008
Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospectsAchille Aouba, Christian Pagnoux, Boris Bienvenu, et al.
Clinical and Experimental Rheumatology|April 20, 2017
Reply to: Behçet's disease: an MHC-I-opathy?Dennis McGonagle, Sibel Zehra Aydin, Ahmet Gül, et al.
Arthritis and Rheumatism|February 22, 2011
Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitidesGuillaume Le Guenno, Alfred Mahr, Christian Pagnoux, et al.
Arthritis and Rheumatism|February 12, 2004
Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patientsDominique Bligny, Alfred Mahr, Philippe Le Toumelin, et al.
Pageof 16

Showing results (21-30 of 158) with videos related to

Sort By:
Pageof 16
Presse Medicale (Paris, France : 1983)|November 7, 2016
[Adult Langerhans cell histiocytosis]Mathilde de Menthon, Véronique Meignin, Alfred Mahr, et al.
Rheumatology International|June 27, 2024
Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitionersLukas Joos, Solange Gonzalez Chiappe, Thomas Neumann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2018
Nomenklatur der kutanen Vaskulitiden - deutschsprachige Definitionen des Dermatologischen Anhanges zur Chapel Hill Consensus ConferenceCord Sunderkötter, Peter Lamprecht, Alfred Mahr, et al.
Presse Medicale (Paris, France : 1983)|March 16, 2013
L47. Single-organ vasculitis: conceptual and practical considerationsAlfred Mahr, Maxime Battistella, Jean-David Bouaziz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2018
Nomenclature of cutaneous vasculitides - German translation of the dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesCord Sunderkötter, Peter Lamprecht, Alfred Mahr, et al.
Presse Medicale (Paris, France : 1983)|September 4, 2012
[Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspects]Séverin Chaigne-Delalande, Mathilde de Menthon, Estibaliz Lazaro, et al.
Clinical Reviews in Allergy & Immunology|February 14, 2008
Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospectsAchille Aouba, Christian Pagnoux, Boris Bienvenu, et al.
Clinical and Experimental Rheumatology|April 20, 2017
Reply to: Behçet's disease: an MHC-I-opathy?Dennis McGonagle, Sibel Zehra Aydin, Ahmet Gül, et al.
Arthritis and Rheumatism|February 22, 2011
Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitidesGuillaume Le Guenno, Alfred Mahr, Christian Pagnoux, et al.
Arthritis and Rheumatism|February 12, 2004
Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patientsDominique Bligny, Alfred Mahr, Philippe Le Toumelin, et al.
Pageof 16